Considerations When Transferring Clinical Investigation Oversight to Another IRB: Guidance for IRBs, Clinical Investigators, and Sponsors
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 23, 2014
May 7, 2020
fe8296e5-3ca7-4209-9920-27aa4635ee35
Related Documents
Financial Disclosure by Clinical Investigators: Guidance for Clinical Investigators, Industry,and FDA Staff
Guidance DocumentFebruary 1, 2013Office of the Commissioner
FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND: Frequently Asked Questions: Guidance for Industry and FDA Staff
Guidance DocumentMarch 1, 2012Office of the Commissioner
IRB Continuing Review After Clinical Investigation Approval: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentFebruary 27, 2012Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox